Protein could be a target for treating people who have the blood disorder
Bethesda, Maryland–(ENEWSPF)–October 13, 2011. National Institutes of Health-funded scientists have corrected sickle cell disease in adult laboratory mice by activating production of a special blood component normally produced before, but not after, birth.
“This discovery provides an important new target for future therapies in people with sickle cell disease,” said Susan B. Shurin, M.D., acting director of the NIH’s National Heart, Lung,…
